Arthur J. Gallagher & Co.
NYSE-AJG
Company Overview
Arthur J. Gallagher & Co., together with its subsidiaries, provides insurance brokerage, consulting, third-party claims settlement, and administration services in the United States, Australia, Bermuda, Canada, the Caribbean, New Zealand, India, and the United Kingdom. It operates through Brokerage and Risk Management segments. The Brokerage segment consists of retail and wholesale insurance brokerage operations; assists retail brokers and other non-affiliated brokers in the placement of specialized and hard-to-place insurance; acts as a brokerage wholesaler, managing general agent, and managing general underwriter for distributing specialized insurance coverage's to underwriting enterprises. This segment also performs activities, including marketing, underwriting, issuing policies, collecting premiums, appointing and supervising other agents, paying claims, and negotiating reinsurance; and offers brokerage and consulting services to businesses and organizations, including commercial, not-for-profit, and public entities, as well as individuals in the areas of insurance placement, risk of loss management, and management of employer sponsored benefit programs. The Risk Management segment provides contract claim settlement and administration services to enterprises and public entities; and claims management, loss control consulting, and insurance property appraisal services. The company offers its services through a network of correspondent insurance brokers and consultants. It serves commercial, industrial, public, religious, and not-for-profit entities. The company was incorporated in 1927 and is headquartered in Rolling Meadows, Illinois.
Name
Arthur J. Gallagher & Co.
CEO
Mr. J. Patrick Gallagher Jr.
Website
www.ajg.com
Sector
Insurance
Year Founded
1927
Profile
Market Cap
$64.56B
EV
$71.79B
Shares Out
219.11M
Revenue
$10.39B
Employees
50,669
Margins
Gross
43.38%
EBITDA
31.56%
Operating
24.08%
Pre-Tax
13.67%
Net
10.98%
FCF
22.46%
Returns (5Yr Avg)
ROA
3.14%
ROTA
20.5%
ROE
12.64%
ROCE
10.22%
ROIC
7.6%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$286.14
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$1,415.3M
Net Debt
$7,198.6M
Debt/Equity
0.74
EBIT/Interest
7.41
Growth (CAGR)
Rev 3Yr
11.84%
Rev 5Yr
8.82%
Rev 10Yr
10.64%
Dil EPS 3Yr
4.76%
Dil EPS 5Yr
7.05%
Dil EPS 10Yr
9.3%
Rev Fwd 2Yr
13.83%
EBITDA Fwd 2Yr
16.14%
EPS Fwd 2Yr
14.24%
EPS LT Growth Est
12.87%
Dividends
Yield
—
Payout
43.78%
DPS
$2.3
DPS Growth 3Yr
7.33%
DPS Growth 5Yr
6.48%
DPS Growth 10Yr
4.94%
DPS Growth Fwd 2Yr
8.02%